Physician profile
Corinne H Case
NPI 1053661603
$6,456.44
in general payments reported to CMS, 2019-2025
7 companies · $2,086 in 2025
The $2,086 reported for 2025 was more than what 91% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $307 · 2023: $588 · 2024: $3,351 · 2025: $2,086.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,017 · Travel and Lodging: $2,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,016.94 |
| Travel and Lodging | $2,007.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $4,134.30 | 2024-2025 | |
| Abbvie INC. | $1,462.11 | 2023-2025 | |
| Allergan, INC. | $431.94 | 2021-2022 | |
| Revance Therapeutics, INC. | $319.70 | 2024-2025 | Daxxify |
| Galderma Laboratories, L.P. | $70.33 | 2023 | Dysport |
| Solta Medical, A Division of Bausch Health US, LLC | $20.95 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $17.11 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corinne Case listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.